Mission & Objective

Sensory Arts & Science develops sensory testing and measurement products that provide better ways to detect and objectively measure the level of severity of conditions and diseases that affect the human senses. The center of of these sensory functions are the 12 cranial nerves.

Our prevention and early intervention approach helps ensure better outcomes and reduced overall incidence, and therefore the associated cost of care.

We model our business and innovation process after the wisdom of prolific inventor and founding father Benjamin Franklin. While prevention is always our first goal, we believe that early detection and the ability to measure or quantify a condition is usually the next best thing.

Our principal objective is to develop:

• A comprehensive set of tools for managing the occurrence, severity, and duration of certain targeted health and safety issues and conditions;
  
  
• In conjunction with healthcare experts and opinion leaders, and peer reviewed by key industry participants;
  
  
• Whose value proposition involves prevention and early detection, thereby reducing incidence and cost, increasing the likelihood of full recovery, and improving outcomes and therefore quality of life.

Our Business Model

Our business model can be generally described as a continuous innovation-to-commercialization process. Health screening and disease management technologies are conceived, followed by a process to prove the viability of the concept and then to protect the resulting Intellectual Property.

Based on the outcome of this proof of concept phase, we will build, test, and commercialize a product or technology that can then be licensed to a partner with market reach, or we will construct and launch a new company specifically around the new product or technology.

Our innovation model is simple and elegant, and a proven way to create sustainable value and competitive advantage.

Leadership

Dave Davis, Managing Partner

Dave is the founder of Sensory Arts & Science, with more than 30 years of healthcare, corporate IT management and entrepreneurial experience. Over the last 20 years, Dave has founded and led several successful technology ventures, including companies in systems integration, healthcare technology, and Internet/new media. Throughout his career, Dave has provided management and strategic consulting services to some of America´s most prestigious companies and has been a featured speaker on topics such as technology futures and entrepreneurship. Dave earned a Bachelor´s Degree in Business Administration from Ursinus College, and is the holder of several issued and pending patents.

Dave leads the organization, defining its vision and strategy, and building a team and strategic relationships that enable the Company to fulfill its plan and vision for leadership in the area of sensory health and disease management technologies.

Medical/Scientific Advisory Board

Peter Febbroriello

Peter´s background is varied and fascinating. He is the founder and principal of the Research Support Group, where he provides a range of R&D services to companies large and small. His background includes significant work and achievement in mechanical, electrical, and bio-medical engineering. He has authored a number of important studies in biophysics and biochemistry, and has recently provided R&D assistance to the University of Connecticut Health Center, Knolls Atomic Power Laboratory, and General Electric. Peter holds a Bachelor´s Degree in Biology/Pre-Med from University of Connecticut.

Avery Gilbert, Ph.D.

Dr. Gilbert is a sensory psychologist specializing in odor perception, with over 16 years experience in the field of human olfaction. He is currently President of Synesthetics, Inc., a multisensory research and consulting company specializing in the consumer impact of smell. He is the former President of the Sense of Smell Institute, a not-for-profit organization and global resource for the olfactory sense. Avery is also the former Vice President of Sensory Psychology at Givaudan Roure Fragrances, and a faculty member at the Monell Chemical Senses Center.

Michael Jones, Ph.D.

Aureliu Porumbescu, Ph.D.

Robert C. Sergott, M.D.

Jeff Vachon

Investor Relations

Sensory Arts & Science is a privately held, self-financed company. From time to time, the company offers financial participation in products or projects that would benefit from strategic partnerships or require significant resources to successfully develop and commercialize. We prefer to work with strategic investors, whether companies or individuals.

For more information on current opportunities and participation, please contact Dave Davis, Managing Partner.